Services

  1. Scale Your Vaccine With Path-To-PAD 3/1/2024

    The COVID-19 pandemic highlighted the urgent need for a quick, efficient, and scalable vaccine production process. Resilience's Vaccine Path-To-PAD (Process and Analytical Development) program provides a clear and easy path to maximize yields at the beginning of development, with deep expertise in vaccines, robust expression platforms, and high-quality Vero and Quail cell lines.

  2. Lentiviral Vectors 2/14/2024

    Leveraging experience, knowledge, and expertise from almost three decades of viral vector development and manufacturing, we offer a scalable, reproducible, and efficient development solution to de-risk lentivirus production.

  3. Process Development 1/25/2024

    EirGenix is a contract development and manufacturing organization that performs high quality and cost-effective services supporting our clients in development, analytical testing, and GMP manufacturing of biopharmaceuticals from pre-clinical to commercial manufacturing

    EirGenix has strong process development capabilities in both microbial and mammalian systems to provide our clients process development, process optimization, and process troubleshooting. We have successfully delivered results to meet clients’ requirement in product productivity, product quality, and process cost effectiveness. Our previous project experience includes recombinant proteins, plasmid DNA, fusion proteins, monoclonal antibodies, and biosimilars.

  4. cGMP Manufacturing - Mammalian System 1/25/2024

    Review how a comprehensive cGMP manufacturing facility is poised to support the development and manufacture of your mammalian cell program.

  5. Cell Line Development 1/25/2024

    EirGenix provides comprehensive cell line development services from DNA replication to the generation of stable producer cell lines for further process development and manufacturing. Our goal is to assist our clients in identifying the most favorable cell line expression system and provide optimization to achieve or surpass expected project targets.

  6. Antibody-Drug Conjugate 1/25/2024

    EirGenix provides client-oriented contract development and manufacturing services for biologics, especially monoclonal antibodies and biosimilars. Combining the capabilities of EirGenix’s strategic partner, Formosa Laboratories, Inc, a high potency API manufacturer, we offer integrated services for Antibody Drug Conjugate (ADC) development and manufacturing.

  7. cGMP Manufacturing - Microbial System 1/25/2024

    Learn how our 4,000-square-foot cGMP manufacturing site is purpose-built to support your microbial program from pre-clinical to commercial manufacturing.

  8. Drug Product Development Services 11/2/2023

    Leveraging expertise in formulation development and advanced technical capabilities can help accelerate your drug product to market with ease.

  9. Delivering LVV Material In An Accelerated Timeline 9/19/2023

    Explore the benefits of the Lentiviral vector (LVV) expansion to our AGCellerate program, designed to deliver GMP material for clinical trials in an accelerated timeline.

  10. Custom Chemical Synthesis 9/19/2023

    Leverage our technical expertise as well as our comprehensive facilities and equipment for robust support of your project's chemical synthesis requirements.